Literature DB >> 1241899

The dosage of co-trimoxazole in childhood.

A S Fowle, A Bye, F Hariri, D Middlemiss, K Naficy.   

Abstract

Co-trimoxazole, a mixture of one part trimethoprim (TMP) and five parts of sulphamethoxazole (SMX) in fixed ratio was given to 48 children aged between one and 48 months twice daily for up to seven days. Twenty were relatively healthy and 28 were very ill. Dosage was based on age. Plasma concentrations of both drugs were measured just before a dose was due and some three hours later. They were in the efective but not toxic range and serve to justify the simple regimen which generated them.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1241899     DOI: 10.1007/bf00567118

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  [Sulfamethoxazole; experimental and clinical studies on a new sulfonamide in children].

Authors:  M RENTSCH
Journal:  Dtsch Med Wochenschr       Date:  1962-03-09       Impact factor: 0.628

2.  Fallacy of per-weight and per-surface area standards, and their relation to spurious correlation.

Authors:  J M TANNER
Journal:  J Appl Physiol       Date:  1949-07       Impact factor: 3.531

3.  Trimethoprim-sulfamethoxazole: absorption, excretion, and toxicity in six children.

Authors:  E B Lewin; J O Klein; M Finland
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

4.  Pharmacokinetic studies of trimethoprim-sulfamethoxazole in children with gastroenteritis.

Authors:  M I Marks; M Kazemi; B Hales; A H Neims
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

5.  The dosage of septrin.

Authors:  A S Fowle
Journal:  Med J Aust       Date:  1973-06-30       Impact factor: 7.738

6.  Pharmacokinetics of trimethoprim and its combination with sulfamethoxazole in man after single and chronic oral administration.

Authors:  H Nolte; H Büttner
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

7.  Modification of an automated method for measurement of sulfamethoxazole and its major metabolite in biological fluids.

Authors:  A Bye; A F Fox
Journal:  Clin Chem       Date:  1974-02       Impact factor: 8.327

8.  Trimethoprim, a sulphonamide potentiator.

Authors:  S R Bushby; G H Hitchings
Journal:  Br J Pharmacol Chemother       Date:  1968-05

9.  Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy.

Authors:  S R Bushby
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

10.  Spectrofluorimetric method for the determination of trimethoprim in body fluids.

Authors:  D E Schwartz; B A Koechlin; R E Weinfeld
Journal:  Chemotherapy       Date:  1969       Impact factor: 2.544

View more
  2 in total

1.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

Review 2.  The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues.

Authors:  D S Reeves; P J Wilkinson
Journal:  Infection       Date:  1979       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.